Jubilant Life Sciences has issued Commercial Papers (CPs) worth Rs 80 crore on May 10, 2018. The company has issued two Papers, one worth Rs 50 crore and other worth Rs 30 crore.
The tenure of instrument is 21 days for Paper worth Rs 50 crore and will mature on May 31, 2018, while the tenure of instrument is 14 days for Paper worth Rs 30 crore and will mature on May 24, 2018.
Jubilant Life Sciences is an integrated global pharmaceutical and life sciences company engaged in Pharmaceuticals, Life Science Ingredients and Drug Discovery Solutions.